Case Analysis on

BIOCON

KIRAN MAZUMDAR SHAWS ENTREPRENEURIAL DREAM

By
Harish (2t3-08)
Sai Sowjanya(2t3-17)
J.Ramya (2t3-20)
Agasthia (22005)
Jyothilakshmi (220-15)
Shruthi(220-76)
Adithya(220-95)

INTRODUCTION
Chairperson and CEO of Biocon Ltd, Indias
largest Biotechnology company.
Born on March 23, 1953
Schooling at Bishop Cotton Girls School
and Mount Carmel College, Bangalore
B.Sc. in Zoology from Bangalore University
in 1973
Ballarat University in Melbourne,
Australia and qualified as a master
brewer.
Awarded honorary doctorates from
University of Abertay, Dundee, U.K.
(2007), University of Glasgow, U.K. (2008)
and Heriot-Watt University, Edinburgh,
U.K. (2008)

HER CAREER

Trainee brewer in Carlton & United Beverages in 1974

Became Indias first Brew Master

Switch of occupation

Trainee Manager with Biocon Biochemical Limited in Ireland

in 1978

Founded Biocon India in collaboration with Biocon

Biochemical Limited

Prerequisites Of A Successful Entrepreneur

Problem Solver
Adaptability
Personal Responsibility Taker
Empirical Optimism
Resourcefulness
Endurance
Insight
Humility
Awareness
Confidence
Decisiveness
Personable
Intelligence
Effective Communicator

Glass Ceiling
DEFINITION:A glass ceiling is a political term used to describe "the unseen, yet
unbreachable barrier that keeps minorities and women from rising to the
upper rungs of the corporate ladder, regardless of their qualifications or
achievements.
The Indian corporate has been largely male dominated, women have been
able to make a mark, but not at the same speed as is seen in the rest of the
world.
In India, only about 25 percent of the business leadership comprises
women. Whereas when compared to other countries, women comprise
nearly 60 percent of the business leadership.
Women get so accustomed to their existing job role, which prevents them
from reaching the top level.
Moreover the organization also has a feeling that it is not worth investing
in because, they would get married, have a baby and quit.
The challenges might continue to exist, but there is no doubt that a greater
representation of women at the workplace is vital today.

Women like Kiran Mazumdar Shaw (CEO of Biocon, India), Ekta

Kapoor, Joint Managing Director and Creative Director of Balaji
Telefilms , Swati A. Piramal, Vice Chairperson of Piramal Life Sciences
and others of their ilk rub shoulders with men in board rooms and are
continuously proving that women are and can be as successful as men.

REASONS FOR BIOCONS SUCCESS

No, that was not only the reason for her success.
The ability to attract and motivate good people was a key
factor behind Biocons success.
People were hand picked by kiran Mazumdar, they grew with
the company and could not think of working for any other
company.

Biocon has entrepreneurship ,drive ,and scientific talent in

abundance.

 Biocon emerged as an integrated biotechnology enterprise

with presence in biopharmaceuticals, enzymes , custom
research , clinical research.
Biocon was Indias largest biotechnology company in terms
of revenues.
The partnership with Cuban institute CIMAB results to
launch the Indias first anti-cancer drug (BIOMAB-EGFR).

CHALLENGES FACED
Personal challenges
Youthful age
Gender

Unfamiliar business
Lack of funds/ assets
Infrastructure

Quality
Managing investors expectations

 Biotechnology has transformed many parts of the chemical

industry, agriculture and medicine.

The consumption of biotech products in India was expected to
quadruple within a decade.
The human and animal segment of the industry alone was
growing by at least 20%.
In 1999, Indian Biotech Industry contributes to 1.5% of the global
biotech industry.
In India 800 Companies were operating in all sectors of
biotechnology, but only 25 were working in the modern biotech
sectors.

ADVANTAGES OF BIOTECH INDUSTRY

IN INDIA
Rich Bio-diversity

Varied Species of flora and fauna.

Varied climatic zones.
Large population and varied demography.

Largest agriculture sector.

World class information technology.
Vast pool of talented and skilled man power.
English as the accepted business language.
Lower operational costs and technologies.

 Increasing Government support for bio technology industry.

Government

is implementing a national Biotechnology

Development Strategy (NBDS) and establishing a national
Biotechnology Regulatory Authority (NBRA) .
100% FDI in biotechnology sector.
Special tax benefits
India had proved its competency in selected areas of
biotechnology such as bioprocess engineering ,skills in gene
manipulation of microbes and animal cells, capacity in
downstream processing and isolation methods, and its
competence in recombinant DNA technology of plants and
animals.

 Kiran Mzumdar Shaw steered the company through several

reinventions, first moving from being an enzymes maker to stains

and when prices crashed & chinese competition intensified, she
shifted focus to bio-pharma. Now she is focusing on three main
businesses-Biocon, Syngene & Clinigene and the company as a
major biopharma company.
Kiran Mazumdar Shaw is aware that the real opportunity lies in

the US and Western Europe, where hundred of billions of dollar

are spent on pharmaceuticals every year. However she also
realizes that such markets are difficult to enter as regulatory
charges are high and there are many large competitors, much
larger than Biocon.

PERSONALITY
High self esteem
Loves and believes in herself
Tradition and culture
High on conscientiousness
Reliable
Responsible
Organized
Dependable
High on agreeableness
Warm with employees, stakeholders
Trust
High on emotional stability
Positive emotional stability

Transformational Leadership
Behavior:
Count on every one to give best.
Transform teams even under unfavorable
conditions
Serve as role model
How this works: By pursuing innovation with
strategic actions.
Motivate group by strengthening team
optimism and commitment also enthusiasm.

THANK YOU